Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity C.-J. Kim, W.S. Choi, Y. Jung, S. Kiem, H.Y. Seol, H.J. Woo, Y.H. Choi, J.S. Son, K.-H. Kim, Y.-S. Kim, E.S. Kim, S.H. Park, J.H. Yoon, S.-M. Choi, H. Lee, W.S. Oh, S.-Y. Choi, N.-J. Kim, J.-P. Choi, S.Y. Park, J. Kim, S.J. Jeong, K.S. Lee, H.C. Jang, J.Y. Rhee, B.-N. Kim, J.H. Bang, J.H. Lee, S. Park, H.Y. Kim, J.K. Choi, Y.-M. Wi, H.J. Choi Clinical Microbiology and Infection Volume 22, Issue 10, Pages 880-886 (October 2016) DOI: 10.1016/j.cmi.2016.07.017 Copyright © 2016 Terms and Conditions
Fig. 1 Geographic distribution of the participating 31 hospitals in South Korea. MERS, Middle east respiratory syndrome. Clinical Microbiology and Infection 2016 22, 880-886DOI: (10.1016/j.cmi.2016.07.017) Copyright © 2016 Terms and Conditions
Fig. 2 STROBE flowchart of participating population. ELISA, enzyme-linked immunosorbent assay; IIFT, indirect immunofluorescence test; MERS, Middle east respiratory syndrome. Clinical Microbiology and Infection 2016 22, 880-886DOI: (10.1016/j.cmi.2016.07.017) Copyright © 2016 Terms and Conditions